EN DE
Watch Arteris Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Arteris Inc (AIP) fair value: what the stock is really worth

As of Oct 28, 2026: fair value (intrinsic value) of Arteris Inc stock $2.01, price $21.43, upside -90.6%, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology US

AI Arteris Inc logo Thin data Oct 28, 2026

Arteris Inc

AIP · US
Very expensive, weak qualityAn uptrend, but price far above fair value and weak quality.Plus: Revenue last quarter +46% vs. a year ago.

Our calculation puts a fair price 91% below what the stock costs today.

Generates free cash flow
Quality 46/100
Mixed Growth (revenue 5y +17.3 %/yr in USD)
Negative equity (buybacks among others)
Insider activity 40/100
Fair value $2.01 · Strongly overvalued (−90.6%)
Loss-making · -46.7% net margin (TTM)
Trails peers (1/8)
Narrow moat 15/100 · thin data
Thin data
Structural break⟳ Cyclical⚠ Dilution
Watch Arteris Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$48.59 $3.36 Fair Value $2.01 Oct 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 28, 2026.

How to read this chart

60‑month range $3.36 – $48.59 · fair‑value band $1.44 – $2.73 · the $21.43 price screens above the $2.01 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 28, 2026.

Follow Arteris in your weekly email

Every Wednesday you see whether Arteris is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.

Show moreShow less

It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets.

The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache.

It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler.

In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services.

It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.

Stock analysis

Arteris Inc (AIP) currently trades at $21.43, while our model-based Fair Value estimate is $2.01, 90.6% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $2.38 per share, and 0 of the 6 models we run sit above the $21.43 price.

Bear case: the Multiples group reads lowest at $1.92, and 6 of the 6 models stay below the price. Data coverage for this calculation is low.

Scenario range: $1.44 (bear) to $2.73 (bull), the price of $21.43 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Arteris Inc reported revenue of $70.6M in FY2025 versus $37.9M in FY2021, a compound +16.8%/yr. Reported net income was −$34.7M in FY2025.

Key figures

Market cap $1.0B Small · P/S ratio 11.3 · EPS (TTM) $−0.8700 · Net margin −46.7% · Return on equity −131% · Return on assets (EBIT) −27.2% · Operating margin −48.5% · Revenue (TTM) $84.6M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 15 out of 100 (low confidence).

What moves the price

The share trades about 56% below its 52-week high and 74% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −6% fair-value upside, at −91%, AIP screens richer than that median.

Fair Value models

Bear $1.44 Fair Value $2.01 Bull $2.73
Price $21.43 · Upside -90.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $1.73 $2.31 $3.57 80
Growth DCF $1.69 $2.36 $3.21 79
5Y Revenue Exit $1.69 $2.51 $3.67 72
All 6 models by family
DCF Models
FCF DCF $1.73 $2.31 $3.57 80
5Y Revenue Exit $1.69 $2.51 $3.67 72
10Y Revenue Exit $1.66 $2.38 $3.54 66
Multiples
EV/Revenue $1.49 $1.92 $2.34 54
Growth DCF
Growth DCF $1.69 $2.36 $3.21 79
Rev-Margin DCF $1.69 $2.48 $3.60 72

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 35
How much profit the company makes from its sales and capital
Quality Growth 71
Are margins and returns getting better?
Cashflow 53
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Momentum 42
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 57
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+22.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.3%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−11.9% (2020) → −47.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+67.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+21.1%
Yearly sales growth analysts expect, extended to five years.
The revenue jump in 2026 (+37.0%) comes with 16% more shares (acquisition or merger paid in stock). Per share it is about +17.9%. The comparison above is unreliable in such a year.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +63.3% a year for the price and +18.3% for the forecasts.
Forecast 2026 (sales)+37.0%
Forecast 2027 (sales)+21.0%
Projected 2028 (sales)+18.6%
Projected 2029 (sales)+16.3%
Projected 2030 (sales)+13.9%

AIP screens overvalued: fair value 91% below the price. Compare with NVIDIA Corporation →

Compare Arteris Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors · 344 stocks

Beats the industry median on 1/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −90.6% · Bottom 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −30.2% · Bottom 25%
Net margin (12 months) −46.7% · Bottom 25%
Operating margin (12 months) −48.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 46.2% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Semiconductors median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 11.97× · Priciest 25%
Price / free cash flow 189.6× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)100 · sector 96
PAST (return on equity)0 · sector 28
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 18

VALUE 0: the price sits above our fair-value range.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Semiconductors stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Micron Technology, Inc MU $877.55 $1,770 +102% vs AIP
SK hynix Inc 000660 1,341,000 KRW 1,501,896 KRW +12% vs AIP
Taiwan Semiconductor Manufacturing Company TSM $436.87 $480.56 +10% vs AIP
NVIDIA Corporation NVDA $210.96 $198.56 −6% vs AIP
Broadcom Inc AVGO $321.68 $300.84 −6% vs AIP
Marvell Technology, Inc MRVL $233.78 $101.64 −57% vs AIP
Intel Corporation INTC $86.96 $26.21 −70% vs AIP
Advanced Micro Devices, Inc AMD $516.79 $148.70 −71% vs AIP
Texas Instruments Incorporated TXN $308.91 $81.25 −74% vs AIP
Arm Holdings ARM $223.35 $45.16 −80% vs AIP

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Arteris Inc · Fair Value
$2.01 −91%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Arteris Inc Fair Value". https://www.fairvalue-calculator.com/stock/AIP

Frequently asked questions

Is Arteris Inc (AIP) overvalued or undervalued?
As of Oct 28, 2026, our model estimates a fair value of $2.01 versus a price of $21.43, about −91% upside (overvalued).
What is the fair value of AIP?
Our model-based fair value for Arteris Inc is $2.01 (as of Oct 28, 2026), built from audited fundamentals. The current price: $21.43.
What is the quality score of AIP?
Arteris Inc has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Arteris Inc (AIP)?
Our model-based price target is the fair value of $2.01 (as of Oct 28, 2026) from 6 valuation models. Cautious scenario $1.44, optimistic scenario $2.73. It is a calculation from audited fundamentals, not an analyst target.
What is the Arteris Inc stock forecast for 2026?
Our models put fair value at $2.01, about −91% upside versus a price of $21.43 (overvalued). Cautious scenario $1.44, optimistic scenario $2.73. The calculation is refreshed regularly with new filings.
What is the revenue of Arteris Inc (AIP)?
Arteris Inc reported trailing-twelve-month revenue of about $84.6M (latest available figure, as of Oct 28, 2026).
What growth is priced into Arteris Inc (AIP)?
For today's price to be fair in a discounted-cash-flow model, Arteris Inc would have to grow free cash flow by +67.2 % per year for five years (discount rate 13.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.3 % per year. As of Oct 28, 2026.
What discount rate (WACC) does the fair value of AIP use?
Our models discount Arteris Inc at 13.7 %: a base by market capitalisation (small), damped by beta 1.90, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Arteris Inc that is +67.2 % per year a year over ten years, using the same discount rate (13.7 %) and the same formula as our fair value.
How much growth has Arteris Inc (AIP) delivered so far?
Over the past 5 years revenue at Arteris Inc grew +17.3 % a year. The price currently implies +67.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Arteris Inc (AIP) growing?
The median revenue growth in the sector is +10.8 % a year. That is the yardstick for the growth priced into Arteris Inc (+67.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Arteris Inc (AIP)?
The free-cash-flow yield on the price is 0.53 %: that much free cash flow Arteris Inc produces per unit of market value. When it exceeds the discount rate of our models (13.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Arteris Inc (AIP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Arteris Inc it is $2.01 per share (as of Oct 28, 2026), against a price of $21.43. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Arteris Inc stock overvalued or undervalued in 2026?
As of Oct 28, 2026, AIP trades above its calculated fair value: price $21.43, fair value $2.01, a gap of about −91% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIP?
No. The price is what the market pays today ($21.43); the fair value is what the company's own numbers justify ($2.01). For Arteris Inc the two are $19.42 per share apart. That gap is exactly why we show both numbers side by side.
How much is Arteris Inc worth?
The market values Arteris Inc at about $1.0B (market capitalisation, as of Oct 28, 2026). Per share that is $21.43; our models calculate a fair value of $2.01 per share.
What do the bullish and bearish scenarios say about AIP?
Our models span a range for Arteris Inc: cautious scenario $1.44, base $2.01, optimistic $2.73 per share (as of Oct 28, 2026, price $21.43). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Arteris Inc (AIP)?
Balance-sheet figures for Arteris Inc (as of Oct 28, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is AIP from its 52-week high?
Arteris Inc trades at $21.43, about 56% below its 52-week high of $48.59 and 74% above the low of $12.32 (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of $2.01 is for.
Which stocks are comparable to Arteris Inc?
From the same area (Technology) we also value NVIDIA Corporation, Taiwan Semiconductor Manufacturing Company, Broadcom Inc, Micron Technology, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Arteris Inc stock attractive at the current price?
The data as of Oct 28, 2026: price $21.43, calculated fair value $2.01 (−91%), Quality Score 46/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AIP calculated?
We run Arteris Inc through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $2.01, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Arteris Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Arteris Inc (AIP)?
The closing price on Oct 28, 2026 was $21.43. Our model-based fair value is $2.01, about −91% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Arteris Inc right now?
The price sits above even our optimistic bull case ($2.73). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($1.44 to $2.73) leaves room in how you read the outcome.

Key figures of Arteris Inc

How large is the market capitalisation of Arteris Inc (AIP)?
The market capitalisation of Arteris Inc is $1.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Arteris Inc (AIP)?
The price-to-sales ratio of Arteris Inc is 11.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Arteris Inc (AIP)?
Earnings per share at Arteris Inc are $−0.8700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Arteris Inc (AIP)?
The net margin of Arteris Inc is −46.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Arteris Inc (AIP)?
The return on equity (ROE) of Arteris Inc is −131% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Arteris Inc (AIP)?
On an EBIT basis the return on assets of Arteris Inc is −27.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Arteris Inc (AIP)?
The operating margin of Arteris Inc is −48.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Arteris Inc (AIP)?
Revenue at Arteris Inc is growing +46.2% versus a year earlier (3y avg +11.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Arteris Inc (AIP) hold?
Arteris Inc holds more cash than debt, $24.8M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Arteris Inc in the live analysis

One click puts Arteris Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.